GlassScriptPhysician profile
Karla Schlimgen
NPI 1023121233
$760.66
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $163 · 2021: $138 · 2022: $180 · 2023: $13.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $162.95 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $113.40 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $92.76 | 2019-2022 | |
| Pfizer INC. | $90.83 | 2019-2022 | |
| Sobi, INC | $43.94 | 2020 | |
| Sanofi Pasteur INC. | $42.90 | 2019-2021 | |
| Hologic Sales and Service, LLC | $35.16 | 2019-2022 | |
| Roche Diagnostics Corporation | $27.87 | 2020 | |
| Ibsa Pharma INC. | $26.34 | 2020 | |
| Corium, LLC | $19.88 | 2022 | |
| Organon LLC | $19.86 | 2022 | |
| Adlon Therapeutics L.P. | $14.76 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.35 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.35 | 2021 | |
| Tris Pharma INC | $14.20 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $13.65 | 2023 | Valtoco |
| Olympus America INC. | $13.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karla Schlimgen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.